<DOC>
	<DOCNO>NCT00204698</DOCNO>
	<brief_summary>This study propose investigate prospectively , presence molecular marker inflammation laryngopharyngeal reflux ( LPR ) patient study effect proton pump inhibitor ( Aciphex ) molecular marker . The investigator evaluate group patient treatment . This group patient untreated laryngopharyngeal reflux diagnose laryngoscopic assessment 24-hour probe .</brief_summary>
	<brief_title>Laryngopharyngeal Reflux Proton Pump Inhibitor ( PPI ) Treatment</brief_title>
	<detailed_description>Objectives : This study propose investigate prospectively , presence molecular marker inflammation LPR patient study effect proton pump inhibitor molecular marker . This study provide important data regard etiology LPR . It also provide vital information present standard treatment LPR universally successful . Patient Selection Criteria : The subject group consist 25 subject untreated LPR diagnose laryngoscopic assessment 24-hour pH probe . Design : The presence proinflammatory cytokine measure gene protein expression level PL biopsy gene specific semiquantitative reverse transcription-polymerase chain reaction Western Blot analysis . Statistical Methods , Data Analysis , Interpretation : Null Hypothesis : There difference cytokine expression posterior larynx patient laryngopharyngeal reflux 10 week treatment Aciphex , proton pump inhibitor . Alternative Hypothesis : There difference cytokine expression posterior larynx patient laryngopharyngeal reflux 10 week treatment Aciphex , proton pump inhibitor . Effect size = 30 % ( base upon review literature cytokines inflammatory state ) Standard Deviation = 30 Standard Effect Size = effect size/standard deviation = 30/30 = 1 With alpha 0.05 , power 0.1 ( 90 % power ) , sample size 22 . Therefore choose 25 subject case error molecular study . Paired t-tests utilized compare difference cytokine level experimental group initiation completion medication .</detailed_description>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Laryngopharyngeal Reflux</mesh_term>
	<mesh_term>Rabeprazole</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<criteria>The subject group consist 25 subject untreated LPR diagnose laryngoscopic assessment 24hour pH probe .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
</DOC>